NCT03757065View on ClinicalTrials.gov

Cell Surface Marker Expression in Autoimmune Diseases

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

October 25, 2019

Study Completion Date

October 25, 2019

Conditions
Systemic Lupus ErythematosusSjogren's SyndromeMultiple SclerosisSystemic SclerosisCrohn's DiseaseUlcerative ColitisInflammatory Myositis
Trial Locations (2)

V6Z 2K5

GI Research Institute, Vancouver

Unknown

Mary Pack Arthritis Center, Vancouver

Sponsors
All Listed Sponsors
lead

Alpine Immune Sciences, Inc.

INDUSTRY

NCT03757065 - Cell Surface Marker Expression in Autoimmune Diseases | Biotech Hunter | Biotech Hunter